Background: Ki-67 proliferation index is widely used for differentiating between high and low-grade gliomas, but differentiating between the same grade IV appears to be more problematic, and the point about its prognostic value for GBM patients remains unclear. To reduce the possibility to find a marked histological heterogeneity, and may contain areas that could be diagnosed as lower grade, in this study we considered a large group of patients with IDH wild-type Glioblastoma (IDH-WT GBM) and we have analyzed previously reported prognostic factors, in regards to their relationship with the Ki-67 expression index. Methods: We explore the prognostic impact of ki-67 index status in 127 patients affected by IDH-WT GBM. We therefore analyzed ...
AIMS: To evaluate the prognostic value and clinical utility of Ki67 tumour cell proliferation index ...
AbstractThe hypoxia and proliferation index increase with grade in human glial tumors, but there is ...
Contains fulltext : 153032.pdf (publisher's version ) (Closed access)Diffuse gliom...
PurposeThe Ki-67/MIB-1 labeling index (LI) is clinically used to differentiate between high and low-...
In our opinion, Ki-67 LI is an important prognostic factor for grade II gliomas, hut it cannot be us...
International audienceBackground & Objectives: Anaplastic oligodendroglioma (AO), IDH-mutant and 1p/...
INTRODUCTION: The biological behavior of intracranial tumors is associated with the main histopathol...
INTRODUCTION: There are several factors predicting evolution in carcinoid tumors (CT) to date includ...
AbstractPurposeSeizures are the most common initial symptom in patients with low-grade gliomas, and ...
Background: Astrocytomas form the largest group of gliomas (>75%) and diffusely infiltrating a...
Düşük dereceli gliomlar, daha yüksek dereceli bir tümöre dönüşme olasılığı olduğu bilinen heterojen ...
Gliomas are the most common and lethal malignant tumors of central nervous system. In 2016, World He...
BackgroundIsocitrate dehydrogenase-wildtype glioblastoma (IDH-wildtype GBM) and IDH-mutant astrocyto...
Abstract Background The Ki-67 index in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) ma...
Preusser M, Hoeftberger R, Woehrer A, Gelpi E, Kouwenhoven M, Kros J M, Sanson M, Idbaih A, Brandes ...
AIMS: To evaluate the prognostic value and clinical utility of Ki67 tumour cell proliferation index ...
AbstractThe hypoxia and proliferation index increase with grade in human glial tumors, but there is ...
Contains fulltext : 153032.pdf (publisher's version ) (Closed access)Diffuse gliom...
PurposeThe Ki-67/MIB-1 labeling index (LI) is clinically used to differentiate between high and low-...
In our opinion, Ki-67 LI is an important prognostic factor for grade II gliomas, hut it cannot be us...
International audienceBackground & Objectives: Anaplastic oligodendroglioma (AO), IDH-mutant and 1p/...
INTRODUCTION: The biological behavior of intracranial tumors is associated with the main histopathol...
INTRODUCTION: There are several factors predicting evolution in carcinoid tumors (CT) to date includ...
AbstractPurposeSeizures are the most common initial symptom in patients with low-grade gliomas, and ...
Background: Astrocytomas form the largest group of gliomas (>75%) and diffusely infiltrating a...
Düşük dereceli gliomlar, daha yüksek dereceli bir tümöre dönüşme olasılığı olduğu bilinen heterojen ...
Gliomas are the most common and lethal malignant tumors of central nervous system. In 2016, World He...
BackgroundIsocitrate dehydrogenase-wildtype glioblastoma (IDH-wildtype GBM) and IDH-mutant astrocyto...
Abstract Background The Ki-67 index in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) ma...
Preusser M, Hoeftberger R, Woehrer A, Gelpi E, Kouwenhoven M, Kros J M, Sanson M, Idbaih A, Brandes ...
AIMS: To evaluate the prognostic value and clinical utility of Ki67 tumour cell proliferation index ...
AbstractThe hypoxia and proliferation index increase with grade in human glial tumors, but there is ...
Contains fulltext : 153032.pdf (publisher's version ) (Closed access)Diffuse gliom...